ZFP57

ZFP57 zinc finger protein, the group of Zinc fingers C2H2-type

Basic information

Region (hg38): 6:29672483-29681155

Previous symbols: [ "C6orf40" ]

Links

ENSG00000204644NCBI:346171OMIM:612192HGNC:18791Uniprot:Q9NU63AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • diabetes mellitus, transient neonatal, 1 (Definitive), mode of inheritance: AR
  • diabetes mellitus, transient neonatal, 1 (Strong), mode of inheritance: AR
  • transient neonatal diabetes mellitus (Strong), mode of inheritance: AR
  • diabetes mellitus, transient neonatal, 1 (Moderate), mode of inheritance: AR
  • diabetes mellitus, transient neonatal, 1 (Strong), mode of inheritance: AR
  • transient neonatal diabetes mellitus (Supportive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Diabetes mellitus, transient neonatal, 1ADEndocrineIndividuals present early in life with failure to thrive, hyperglycemia, and dehydration, and prompt recognition and treatment can reduce morbidityEndocrine18622393
The pathogenesis can involve imprinting defects (eg, paternal UPD, paternal duplication, methylation defects)

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ZFP57 gene.

  • not provided (2 variants)
  • Diabetes mellitus, transient neonatal, 1 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZFP57 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
9
clinvar
12
missense
1
clinvar
42
clinvar
5
clinvar
4
clinvar
52
nonsense
1
clinvar
1
clinvar
2
start loss
0
frameshift
3
clinvar
1
clinvar
4
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
2
clinvar
17
clinvar
19
Total 3 3 46 16 21

Highest pathogenic variant AF is 0.00000656

Variants in ZFP57

This is a list of pathogenic ClinVar variants found in the ZFP57 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-29672507-T-C Uncertain significance (-)1050206
6-29672526-C-T ZFP57-related disorder Likely benign (Dec 14, 2022)2199169
6-29672527-C-G Inborn genetic diseases Uncertain significance (Mar 19, 2024)3334496
6-29672529-C-A Uncertain significance (Apr 04, 2024)3068094
6-29672546-T-C Inborn genetic diseases Uncertain significance (Apr 20, 2024)3334497
6-29672561-C-G Inborn genetic diseases Uncertain significance (Mar 23, 2022)2279577
6-29672566-G-C not specified Uncertain significance (Aug 05, 2015)212639
6-29672582-G-T Inborn genetic diseases Uncertain significance (Sep 27, 2022)2326758
6-29672590-C-A Uncertain significance (Apr 08, 2022)2088219
6-29672639-G-C Diabetes mellitus, transient neonatal, 1 • Monogenic diabetes • ZFP57-related disorder • Inborn genetic diseases Conflicting classifications of pathogenicity (Dec 28, 2023)356211
6-29672685-G-A Inborn genetic diseases Likely benign (Dec 15, 2023)3193160
6-29672727-AG-A Diabetes mellitus, transient neonatal, 1 Pathogenic (Aug 01, 2008)717
6-29672739-G-C Diabetes mellitus, transient neonatal, 1 Pathogenic (Aug 01, 2008)718
6-29672772-G-T Inborn genetic diseases Uncertain significance (Dec 07, 2021)2266219
6-29672828-A-G Inborn genetic diseases Uncertain significance (Dec 19, 2022)2336690
6-29672835-T-C Inborn genetic diseases Likely benign (Oct 03, 2023)3193159
6-29672858-C-A Uncertain significance (Dec 07, 2023)1976445
6-29672881-C-T Diabetes mellitus, transient neonatal, 1 Uncertain significance (Jan 13, 2018)907777
6-29672882-G-A Inborn genetic diseases Uncertain significance (Mar 31, 2024)3334495
6-29672930-C-T Inborn genetic diseases Uncertain significance (Jun 05, 2023)2525094
6-29672985-C-G Uncertain significance (Oct 21, 2021)1346185
6-29672993-G-C Diabetes mellitus, transient neonatal, 1 Conflicting classifications of pathogenicity (Sep 08, 2023)130769
6-29672999-G-C Inborn genetic diseases Uncertain significance (Oct 27, 2021)2208414
6-29673008-T-A not specified • Diabetes mellitus, transient neonatal, 1 Benign (Feb 01, 2024)130773
6-29673025-A-G not specified • Diabetes mellitus, transient neonatal, 1 Benign/Likely benign (Aug 01, 2024)130768

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ZFP57protein_codingprotein_codingENST00000488757 48719
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0005460.717124811091248200.0000361
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.382192850.7700.00001523556
Missense in Polyphen4570.9970.63383944
Synonymous1.21921080.8520.000005611012
Loss of Function0.87668.810.6813.80e-7105

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003080.000287
Ashkenazi Jewish0.000.00
East Asian0.0001120.000111
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.0001120.000111
South Asian0.00006590.0000654
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds to a 5'-TGCCGC-3' consensus sequence and recognizes the methylated CpG within this element (By similarity). Transcription regulator required to maintain maternal and paternal gene imprinting, a process by which gene expression is restricted in a parent of origin-specific manner by epigenetic modification of genomic DNA and chromatin, including DNA methylation. Acts by controlling DNA methylation during the earliest multicellular stages of development at multiple imprinting control regions. Required for the establishment of maternal methylation imprints at SNRPN locus. Acts as a transcriptional repressor in Schwann cells. {ECO:0000250, ECO:0000269|PubMed:18622393}.;
Disease
DISEASE: Transient neonatal diabetes mellitus 1 (TNDM1) [MIM:601410]: Neonatal diabetes is a form of diabetes mellitus defined by the onset of mild-to-severe hyperglycemia within the first months of life. In about half of the neonates, diabetes is transient and resolves at a median age of 3 months, whereas the rest have a permanent form of diabetes. {ECO:0000269|PubMed:18622393}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Intolerance Scores

loftool
0.716
rvis_EVS
1.97
rvis_percentile_EVS
97.58

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.247
ghis
0.391

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.00277

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Zfp57
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype;

Gene ontology

Biological process
regulation of gene expression by genetic imprinting;regulation of transcription by RNA polymerase II;DNA methylation involved in embryo development
Cellular component
nucleus
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding